Key Insights

Highlights

Treatment Research

6 treatments under study, led by Questionnaire Administration

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06997094Phase 1RecruitingPrimary

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Showing all 1 trials

Research Network

Common Treatments

  • Questionnaire Administration1
  • Surgical Procedure1
  • Biospecimen Collection1
  • Chemotherapy1
  • External Beam Radiation Therapy1

Active Sponsors

  • Mayo Clinic1

Top Investigators

Related Conditions

  • Hpvnegative Squamous Cell Carcinoma1
  • Resectable Head And Neck Squamous Cell Carcinoma1
  • Resectable Head And Neck Squamouscell Carcinoma1
  • Resectable Human Papillomavirusindependent Head And Neck Mucosal Squamous Cell Carcinoma1

Activity Timeline